ProMIS Neurosciences, Inc. (PMN)
8.00
+0.10
(+1.20%)
USD |
NASDAQ |
Dec 08, 11:20
ProMIS Neurosciences Research and Development Expense (TTM): 28.34M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Oncolytics Biotech, Inc. | 13.59M |
| Aurinia Pharmaceuticals, Inc. | 29.72M |
| Edesa Biotech, Inc. | 2.547M |
| Lexaria Bioscience Corp. | 8.239M |
| Xenon Pharmaceuticals, Inc. | 270.15M |